1887

Abstract

Hepatitis B virus (HBV) infections represent a global health problem, since these account for 350 million chronic infections worldwide that result in 500 000–700 000 deaths each year. Control of viral replication and HBV-related disease and mortality are of utmost importance. Because the currently available antiviral therapies all have major limitations, new strategies to treat chronic HBV infection are eagerly awaited. Six single-domain antibodies (VHHs) targeting the core antigen of HBV (HBcAg) have been generated and three of these bound strongly to HBcAg of both subtype and . These three VHHs were studied as intrabodies directed towards the nucleus or the cytoplasm of a hepatoma cell line that was co-transfected with HBV. A speckled staining of HBcAg was observed in the cytoplasm of cells transfected with nucleotropic VHH intrabodies. Moreover, an increased intracellular accumulation of hepatitis B e antigen (HBeAg) and a complete disappearance of intracellular HBcAg signal were observed with nuclear targeted HBcAg-specific VHHs. These results suggest that HBcAg-specific VHHs targeted to the nucleus affect HBcAg and HBeAg expression and trafficking in HBV-transfected hepatocytes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.016063-0
2010-03-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/3/643.html?itemId=/content/journal/jgv/10.1099/vir.0.016063-0&mimeType=html&fmt=ahah

References

  1. Bruss, V. ( 2004; ). Envelopment of the hepatitis B virus nucleocapsid. Virus Res 106, 199–209.[CrossRef]
    [Google Scholar]
  2. Bruss, V. ( 2007; ). Hepatitis B virus morphogenesis. World J Gastroenterol 13, 65–73.[CrossRef]
    [Google Scholar]
  3. Butz, K., Denk, C., Fitscher, B., Crnkovic-Mertens, I., Ullmann, A., Schröder, C. H. & Hoppe-Seyler, F. ( 2001; ). Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene 20, 6579–6586.[CrossRef]
    [Google Scholar]
  4. Deres, K., Schröder, C. H., Paessens, A., Goldmann, S., Hacker, H. J., Weber, O., Krämer, T., Niewöhner, U., Pleiss, U. & other authors ( 2003; ). Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299, 893–896.[CrossRef]
    [Google Scholar]
  5. Feld, J., Lee, J. Y. & Locarnini, S. ( 2003; ). New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38, 545–553.
    [Google Scholar]
  6. Feng, Y., Kong, Y. Y., Wang, Y. & Qi, G. R. ( 2001; ). Intracellular inhibition of the replication of hepatitis B virus by hammerhead ribozymes. J Gastroenterol Hepatol 16, 1125–1130.[CrossRef]
    [Google Scholar]
  7. Gordien, E., Rosmorduc, O., Peltekian, C., Garreau, F., Brechot, C. & Kremsdorf, D. ( 2001; ). Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol 75, 2684–2691.[CrossRef]
    [Google Scholar]
  8. Hilleman, M. R. ( 2003; ). Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 21, 4626–4649.[CrossRef]
    [Google Scholar]
  9. Ji, W. & Si, C. W. ( 1997; ). Inhibition of hepatitis B virus by retroviral vectors expressing antisense RNA. J Viral Hepat 4, 167–173.[CrossRef]
    [Google Scholar]
  10. Kann, M., Schmitz, A. & Rabe, B. ( 2007; ). Intracellular transport of hepatitis B virus. World J Gastroenterol 13, 39–47.[CrossRef]
    [Google Scholar]
  11. Kim, T. H., Cho, E. Y., Oh, H. J., Choi, C. S., Kim, J. W., Moon, H. B. & Kim, H. C. ( 2006; ). The degrees of hepatocyte cytoplasmic expression of hepatitis B core antigen correlate with histologic activity of liver disease in the young patients with chronic hepatitis B infection. J Korean Med Sci 21, 279–283.
    [Google Scholar]
  12. Lavanchy, D. ( 2004; ). Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11, 97–107.[CrossRef]
    [Google Scholar]
  13. Rabe, B., Vlachou, A., Pante, N., Helenius, A. & Kann, M. ( 2003; ). Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A 100, 9849–9854.[CrossRef]
    [Google Scholar]
  14. Rosmorduc, O., Sirma, H., Soussan, P., Gordien, E., Lebon, P., Horisberger, M., Brechot, C. & Kremsdorf, D. ( 1999; ). Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. J Gen Virol 80, 1253–1262.
    [Google Scholar]
  15. Seeger, C., Zoulim, F. & Mason, W. S. ( 2007; ). Hepadnaviruses. In Fields Virology, 5th edn, pp. 2977–3029. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams and Wilkins.
  16. Serinoz, E., Varli, M., Erden, E., Cinar, K., Kansu, A., Uzunalimoglu, O., Yurdaydin, C. & Bozkaya, H. ( 2003; ). Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral load. J Clin Gastroenterol 36, 269–272.[CrossRef]
    [Google Scholar]
  17. Serruys, B., Van Houtte, F., Verbrugghe, P., Leroux-Roels, G. & Vanlandschoot, P. ( 2009; ). Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice. Hepatology 49, 39–49.[CrossRef]
    [Google Scholar]
  18. Tuttleman, J. S., Pourcel, C. & Summers, J. ( 1986; ). Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47, 451–460.[CrossRef]
    [Google Scholar]
  19. Xu, R., Cai, K., Zheng, D., Ma, H., Xu, S. & Fan, S. T. ( 2003; ). Molecular therapeutics of HBV. Curr Gene Ther 3, 341–355.[CrossRef]
    [Google Scholar]
  20. Yamamoto, M., Hayashi, N., Takehara, T., Ueda, K., Mita, E., Tatsumi, T., Sasaki, Y., Kasahara, A. & Hori, M. ( 1999; ). Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells. Hepatology 30, 300–307.[CrossRef]
    [Google Scholar]
  21. Ying, C., De Clercq, E. & Neyts, J. ( 2003; ). Selective inhibition of hepatitis B virus replication by RNA interference. Biochem Biophys Res Commun 309, 482–484.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.016063-0
Loading
/content/journal/jgv/10.1099/vir.0.016063-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error